Caribou Biosciences Inc share price logo

Caribou Biosciences Inc Share Price

NASDAQ: CRBU

Small Cap

$2.12

+0.17

(+8.46%)

as on

Caribou Biosciences Inc Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.97
    $2.17
    downward going graph

    7.08%

    Downside

    2.36%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.71
    $3.54
    downward going graph

    66.51%

    Downside

    66.75%

    Upside

    downward going graph

Caribou Biosciences Inc share price movements today

Previous Close
$1.95
Open
$2.03
Volume
3.7M
Day's Low - High
$1.97 - $2.17
52 Week Low - High
$0.71 - $3.54

Caribou Biosciences Inc Historical Returns

1 Month Return
+ 12.77 %
3 Month Return
+ 35.9 %
1 Year Return
+ 172.11 %
3 Year Return
-53.71 %
5 Year Return
0 %

Caribou Biosciences Inc Stock Fundamentals & Key Indicators

Check Caribou Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$188.4M

EPS (TTM)

-1.38

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-130.3M

Revenue (TTM)

11.2M

Profit Margin

0.00%

Return On Equity TTM

-78.97%

Caribou Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Caribou Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Caribou Biosciences Inc image
Caribou Biosciences Inc
BUY$188.4MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$45.0B144.14%145.058.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.0B100.94%28.9832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA123.515.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B52.74%17.9931.41%

Stock Returns calculator for Caribou Biosciences Inc Stock including INR - Dollar returns

The Caribou Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Caribou Biosciences Inc investment value today

Current value as on today

₹2,94,011

Returns

₹1,94,011

(+194.01%)

Returns from Caribou Biosciences Inc Stock

₹1,71,795 (+171.79%)

Dollar Impact

₹22,216 (+22.22%)

Analyst Recommendation on Caribou Biosciences Inc Stock

Based on 15 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Caribou Biosciences Inc. Average target price of $11.12

Caribou Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Caribou Biosciences Inc.

What analysts predicted

80.94%UPSIDE

Target Price

$11.12

Current Price

$2.12

Analyzed by

15 Analysts

Target

$11.12

Caribou Biosciences Inc target price $11.12, a slight upside of 80.94% compared to current price of $2.12. According to 15 analysts rating.

Caribou Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Caribou Biosciences Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Caribou Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
23
3
2
3
2
2
2
2
2
3
Gross Profit
-4
1
1
2
2
-27
2
2
1
3
Operating Income
-14
-37
-46
-43
-38
-38
-42
-47
-29
-28
EBITDA
-13
-36
-45
-42
-37
-37
-41
-34
-26
-27
Interest Expense
-
3
-
-
-
-
-
-
-
-
Depreciation
1
0
0
0
1
1
1
1
0
0
Income Before Tax
-10
-34
-41
-37
-34
-35
-39
-54
-27
-27
Income Tax Expense
-3
0
0
-
-
0
-
-
-
0
Net Income
-10
-34
-41
-37
-34
-35
-39
-54
-27
-26
Net Profit Margin
-42.27%
-969.79%
-1697.57%
-1088.25%
-1713.64%
-1708.71%
-1699.58%
-2028.42%
-1253.32%
-672.11%

Caribou Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
12
9
13
34
9
11
Gross Profit
5
-22
8
10
30
6
7
Operating Income
-34
-36
-66
-106
-116
-166
-136
EBITDA
-30
-35
-65
-95
-112
-162
-132
Interest Expense
0
0
0
8
-
-
-
Depreciation
0
0
0
1
3
3
3
Income Before Tax
-30
-36
-66
-99
-101
-149
-148
Income Tax Expense
-7
-1
0
0
0
0
0
Net Income
-23
-34
-66
-99
-102
-149
-148
Net Profit Margin
-404.82%
-277.55%
-697.26%
-717.79%
-296.05%
-1491.95%
-1327.40%

Caribou Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-34
-41
-37
-34
-35
-39
-54
-27
-26
Operating Cash Flow
-21
-37
-32
-32
-35
-36
-28
-25
-20
Investing Cash Flow
-31
22
21
26
15
49
24
10
17
Financing Cash Flow
0
12
0
0
3
0
0
0
4
Change in Cash
-52
-1
-11
-5
-15
13
-4
-14
1

Caribou Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-34
-66
-99
-102
-149
-148
Operating Cash Flow
-33
-32
-90
-93
-138
-110
Investing Cash Flow
6
-176
-93
-68
86
102
Financing Cash Flow
1
433
2
154
16
4
Change in Cash
-25
224
-182
-7
-34
-3

Global Institutional Holdings in Caribou Biosciences Inc

Funds
Holdings
Dimensional Fund Advisors, Inc.
1.04%
Maverick Capital Ltd
0.68%
Jacobs Levy Equity Management, Inc.
0.85%
AQR Capital Management LLC
0.69%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.6%
See all

Insights on Caribou Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CRBU has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -54.09M → -26.48M (in $), with an average increase of 50.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.19M → 3.94M (in $), with an average increase of 44.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CRBU stock has moved up by 25.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 120.7%

About Caribou Biosciences Inc

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
OrganisationCaribou Biosciences Inc
Headquarters2929 7th Street, Berkeley, CA, United States, 94710
IndustryBiotechnology
CEODr. Rachel E. Haurwitz Ph.D.
E-voting on sharesClick here to vote

Key Management of Caribou Biosciences Inc

Name

Title

Mr. Timothy P. Kelly M.B.A.

Chief Technology Officer

Ms. Barbara G. McClung Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Sriram Ryali M.B.A.

Chief Financial Officer

Mr. Ryan Fischesser

Interim Principal Accounting Officer & Controller

Ms. Reigin Zawadzki

Chief People Officer

Ms. Ruhi A. Khan M.B.A.

Chief Business Officer

Dr. Tina Albertson M.D., Ph.D.

Chief Medical Officer

Dr. Rachel E. Haurwitz Ph.D.

Co-Founder, CEO, President & Director

FAQs

What is Caribou Biosciences Inc share price today?

Caribou Biosciences Inc share price today is $2.12 as on at the close of the market. Caribou Biosciences Inc share today touched a day high of $2.17 and a low of $1.97.

What is the 52 week high and 52 week low for Caribou Biosciences Inc share?

Caribou Biosciences Inc share touched a 52 week high of $3.54 on and a 52 week low of $0.71 on . Caribou Biosciences Inc stock price today i.e. is closed at $2.12,which is 40.03% down from its 52 week high and 198.59% up from its 52 week low.

What is Caribou Biosciences Inc's market capitalisation today?

Caribou Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Caribou Biosciences Inc Stock (CRBU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Caribou Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Caribou Biosciences Inc Shares that will get you 0.7075 shares as per Caribou Biosciences Inc share price of $2.12 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Caribou Biosciences Inc Stock (CRBU) from India?

Indian investors can start investing in Caribou Biosciences Inc (CRBU) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Caribou Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Caribou Biosciences Inc share’s latest price of $2.12 as on April 15, 2026 at 1:29 am IST, you will get 4.7170 shares of Caribou Biosciences Inc. Learn more about fractional shares .